ialurillogo

PATIENTS

Slide background

About

Welcome to iAluRil.co.uk

ialDiagram2iAluRil is a medical device presented in a 50ml pre-filled syringe with a Luer-Lock adaptor for easy use.

iAluRil contains  two active components: 800 mg/50 ml sodium hyaluronate (1.6%) and 1 g /50 ml sodium chondroitin sulfate (2%).

iAluRil can be used for the treatment of:
– Interstitial cystitis
– Painful bladder syndrome
– Recurrent urinary tract infections
– Chemical-/radiation-induced cystitis (including BCG)

iAluRil® is the first intravesical GAG replacement therapy to combine one of the most abundant sulfated GAG molecules located on the bladder wall,1 chondroitin sulfate, with the most integral component of the GAG layer,2 hyaluronic acid. This combination is designed to facilitate faster and more effective restoration of the bladder epithelium.

Manufactured by IBSA FARMACEUTICI ITALIA SRL logoIBSAIT

Under license from NTC S.r.l ntclogo

References: 1) Hurst RE et al. Functional and Structural Characteristics of the Glycosaminoglycans of the Bladder Luminal Surface. J Urol 1987; 138 (2): 433-437. 2) Stryer L. Biochemistry – 4th Edition. W.H. Freeman & Company; 1995. 3) Creta M, Di Meo S, Buonopane R, Imperatore V. Intravesical instillation of hyaluronic acid and chondroitin sulphate for Bacillius Calmette-Guerin induced chemical cystitis. 85th Italian Society of Urology (SIU) Congress, Venice, Italy, 21-24 October 2012.

For further information please call: 01730 231148, email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
Revision reference – iAluRil_2__27/06/2017

Save

Save